医学
血压
重症监护医学
第一行
一线治疗
外科
内科学
化疗
作者
Tianyu Chen,Zhaohua Zhu
出处
期刊:JAMA
[American Medical Association]
日期:2025-09-24
标识
DOI:10.1001/jama.2025.13326
摘要
To the Editor We have 2 concerns about a recent clinical trial1 evaluating the efficacy and safety of subcutaneous zilebesiran combined with first-line oral antihypertensives for continuous blood pressure control.
科研通智能强力驱动
Strongly Powered by AbleSci AI